Subramanian, Ajay http://orcid.org/0000-0001-7892-886X
Nemat-Gorgani, Neda
Ellis-Caleo, Timothy J. http://orcid.org/0000-0002-3217-8335
van IJzendoorn, David G. P. http://orcid.org/0000-0002-2249-5919
Sears, Timothy J. http://orcid.org/0000-0002-4868-1509
Somani, Anish
Luca, Bogdan A.
Zhou, Maggie Y.
Bradic, Martina
Torres, Ileana A.
Oladipo, Eniola
New, Christin
Kenney, Deborah E.
Avedian, Raffi S.
Steffner, Robert J.
Binkley, Michael S.
Mohler, David G.
Tap, William D.
D’Angelo, Sandra P. http://orcid.org/0000-0002-3736-3783
van de Rijn, Matt
Ganjoo, Kristen N.
Bui, Nam Q.
Charville, Gregory W. http://orcid.org/0000-0002-2774-2704
Newman, Aaron M. http://orcid.org/0000-0002-1857-8172
Moding, Everett J. http://orcid.org/0000-0001-7913-5351
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-22-1-0161)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA25542501)
Article History
Received: 24 June 2023
Accepted: 8 February 2024
First Online: 1 March 2024
Competing interests
: W.D.T. has served as a consultant/advisor for Eli Lilly, Daiichi Sankyo, Deciphera, Foghorn Therapeutics, AmMAx Bio, Novo Holdings, Servier, Medpacto, Ayala Pharmaceuticals, Kowa Research Inst., Epizyme (Nexus Global Group), Bayer, Cogent Biosciences, Amgen and PER; has received research funding from Novartis, Eli Lilly, Plexxikon, Daiichi Sankyo, Tracon Pharma, Blueprint Medicines, Immune Design, BioAlta and Deciphera; and has a patent on companion diagnostics for CDK4 inhibitors (4/854,329). S.P.D. has served as a consultant/advisor for EMD Serono, Amgen, Nektar, Immune Design, GlaxoSmithKline, Incyte, Merck, Adaptimmune, Immunocore, Pfizer, Servier, Rain Therapeutics, GI Innovations and Aadi Bioscience and has received research funding from EMD Serono, Amgen, Merck, Incyte, Nektar, Bristol-Meyers Squibb and Deciphera. E.J.M. has served as a paid consultant for Guidepoint. The other authors declare no competing interests.